Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Miqnaf Approved by DCGI, launched May 27, 2025 Used in community-acquired pneumonia and respiratory tract infections Addresses macrolide resistance (azithromycin resistance is widespread) and is quinolone-sparing Dedicated business unit created for specialist-focused commercialization Saudi Arabia: Received Breakthrough Medicinal Product (BMP) status - facilitating accelerated approval 3
In September 2023, she filed a lawsuit against Wegovys manufacturer, Novo Nordisk
Appetite suppression is the standout effect
GLP-1 receptor agonists, such as Ozempic, Wegovy, Zepbound, and Mounjaro, often have monthly costs ranging from $150 to over $1,300 depending on insurance, dose and drug type
Sano R, Shinozaki Y, Ohta T
23, 2024 (HealthDay News) -- The U.S
US$ 21.96
US$ 29.09
US$ 27.69
%20(1).png)
US$ 23.67
US$ 24.05
